SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-054156
Filing Date
2019-10-15
Accepted
2019-10-15 16:17:47
Documents
34
Period of Report
2019-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-17626_110q.htm 10-Q 362986
2 EX-31.1 a19-17626_1ex31d1.htm EX-31.1 10860
3 EX-31.2 a19-17626_1ex31d2.htm EX-31.2 10837
4 EX-32.1 a19-17626_1ex32d1.htm EX-32.1 6332
5 EX-32.2 a19-17626_1ex32d2.htm EX-32.2 6307
  Complete submission text file 0001104659-19-054156.txt   1424321

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20190831.xml EX-101.INS 206146
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20190831.xsd EX-101.SCH 16322
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20190831_cal.xml EX-101.CAL 17935
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20190831_lab.xml EX-101.LAB 145136
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20190831_pre.xml EX-101.PRE 88781
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20190831_def.xml EX-101.DEF 32853
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 191151134
SIC: 2835 In Vitro & In Vivo Diagnostic Substances